
ArrowMark Partners
North America, Colorado, United States, Denver
Description
ArrowMark Partners manages assets on behalf of a diverse group of institutional clients and asset allocators.
Investor Profile
ArrowMark Partners has backed more than 73 startups, with 1 new investments in the last 12 months alone. The firm has led 9 rounds, about 12% of its total and boasts 34 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series C, Series D rounds (top funding stages).
- Majority of deals are located in United States, United Kingdom, France.
- Strong thematic focus on Biotechnology, Health Care, Life Science.
Stage Focus
- Series B (30%)
- Series C (27%)
- Series D (8%)
- Post Ipo Equity (8%)
- Series E (8%)
- Series Unknown (5%)
- Series A (4%)
- Convertible Note (3%)
- Series G (3%)
- Series F (3%)
Country Focus
- United States (96%)
- United Kingdom (1%)
- France (1%)
- Bermuda (1%)
Industry Focus
- Biotechnology
- Health Care
- Life Science
- Pharmaceutical
- Therapeutics
- Biopharma
- Medical
- Genetics
- Medical Device
- Artificial Intelligence (Ai)
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does ArrowMark Partners frequently co-invest with?
Which angels does ArrowMark Partners often collaborate with?
What are some of recent deals done by ArrowMark Partners?
Find More Investors Like ArrowMark Partners
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides










